Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet

PHASE3CompletedINTERVENTIONAL
Enrollment

1,083

Participants

Timeline

Start Date

September 24, 2012

Primary Completion Date

June 3, 2013

Study Completion Date

June 3, 2013

Conditions
Analgesia
Interventions
DRUG

Ibuprofen 600 mg Immediate Release/Extended Release Caplet

Ibuprofen 600 mg Immediate Release/Extended Release Caplet to be adminstered orally (i.e., one caplet every 12 hours, not to exceed 2 caplets per day) for pain.

Trial Locations (18)

21228

Catonsville Pharmacy, Baltimore

23192

Montpelier Pharmacy, Inc., Montpelier

30224

Wynn's Pharmacy Inc., Griffin

55330

Kemper Drug, Elk River

55426

Cub Pharmacy Number 1924, Saint Louis Park

55434

Goodrich Pharmacy, Blaine

64111

Albers' Medical Pharmacy, Kansas City

64485

Countryside Pharmacy, Savannah

66209

Stark Pharmacy, Overland Park

84088

Family Plaza Pharmacy, West Jordan

84121

The Medicine Shoppe, Salt Lake City

84401

The Medicine Shoppe, Ogden

87104

Duran Central Pharmacy, Albuquerque

87571

Total Health and Wellness Center of Taos, Taos

92801

Medical Arts Rexall Pharmacy, Anaheim

92886

B and B Pharmacy, Yorba Linda

98028

Ostrom Drugs, Kenmore

98290

Kusler's Pharmacy, Snohomish

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY